nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—Sulfaphenazole—Dapsone—systemic lupus erythematosus	0.159	1	CrCrCtD
Celecoxib—hematologic cancer—Methylprednisolone—systemic lupus erythematosus	0.0947	0.238	CpDpCtD
Celecoxib—PTGS2—systemic lupus erythematosus	0.0689	0.529	CbGaD
Celecoxib—ALB—systemic lupus erythematosus	0.0614	0.471	CbGaD
Celecoxib—kidney cancer—Hydrocortisone—systemic lupus erythematosus	0.0505	0.127	CpDpCtD
Celecoxib—colon cancer—Betamethasone—systemic lupus erythematosus	0.0427	0.107	CpDpCtD
Celecoxib—colon cancer—Dexamethasone—systemic lupus erythematosus	0.0427	0.107	CpDpCtD
Celecoxib—prostate cancer—Hydrocortisone—systemic lupus erythematosus	0.0365	0.0917	CpDpCtD
Celecoxib—kidney cancer—Betamethasone—systemic lupus erythematosus	0.0308	0.0774	CpDpCtD
Celecoxib—kidney cancer—Dexamethasone—systemic lupus erythematosus	0.0308	0.0774	CpDpCtD
Celecoxib—prostate cancer—Betamethasone—systemic lupus erythematosus	0.0223	0.056	CpDpCtD
Celecoxib—prostate cancer—Dexamethasone—systemic lupus erythematosus	0.0223	0.056	CpDpCtD
Celecoxib—PTGS2—Dapsone—systemic lupus erythematosus	0.0191	0.126	CbGbCtD
Celecoxib—PTGS2—Triamcinolone—systemic lupus erythematosus	0.0166	0.11	CbGbCtD
Celecoxib—PTGS2—Betamethasone—systemic lupus erythematosus	0.0142	0.094	CbGbCtD
Celecoxib—osteoarthritis—Prednisone—systemic lupus erythematosus	0.0125	0.0315	CpDpCtD
Celecoxib—osteoarthritis—Methylprednisolone—systemic lupus erythematosus	0.0125	0.0315	CpDpCtD
Celecoxib—ABCC4—Methotrexate—systemic lupus erythematosus	0.0113	0.0748	CbGbCtD
Celecoxib—ALB—Mycophenolate mofetil—systemic lupus erythematosus	0.0104	0.0691	CbGbCtD
Celecoxib—CYP2C9—Leflunomide—systemic lupus erythematosus	0.00911	0.0603	CbGbCtD
Celecoxib—ALB—Prednisone—systemic lupus erythematosus	0.00835	0.0552	CbGbCtD
Celecoxib—PTGS2—Dexamethasone—systemic lupus erythematosus	0.00826	0.0547	CbGbCtD
Celecoxib—CYP2C9—Dapsone—systemic lupus erythematosus	0.00649	0.043	CbGbCtD
Celecoxib—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.00432	0.0286	CbGbCtD
Celecoxib—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.00427	0.0282	CbGbCtD
Celecoxib—ALB—Methotrexate—systemic lupus erythematosus	0.00419	0.0277	CbGbCtD
Celecoxib—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.0039	0.0258	CbGbCtD
Celecoxib—CYP3A4—Dapsone—systemic lupus erythematosus	0.00377	0.025	CbGbCtD
Celecoxib—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.00327	0.0217	CbGbCtD
Celecoxib—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.00327	0.0217	CbGbCtD
Celecoxib—CYP2C9—cardial valve—systemic lupus erythematosus	0.00305	0.114	CbGeAlD
Celecoxib—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.00281	0.0186	CbGbCtD
Celecoxib—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00281	0.0186	CbGbCtD
Celecoxib—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00277	0.0183	CbGbCtD
Celecoxib—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00263	0.0174	CbGbCtD
Celecoxib—CYP3A4—Prednisone—systemic lupus erythematosus	0.00262	0.0173	CbGbCtD
Celecoxib—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.00257	0.017	CbGbCtD
Celecoxib—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00248	0.0164	CbGbCtD
Celecoxib—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00163	0.0108	CbGbCtD
Celecoxib—MAPK14—blood plasma—systemic lupus erythematosus	0.00104	0.0391	CbGeAlD
Celecoxib—PDPK1—nephron tubule—systemic lupus erythematosus	0.001	0.0377	CbGeAlD
Celecoxib—PDPK1—kidney—systemic lupus erythematosus	0.000882	0.0331	CbGeAlD
Celecoxib—PDPK1—lymphoid tissue—systemic lupus erythematosus	0.000757	0.0285	CbGeAlD
Celecoxib—CYP2C9—urine—systemic lupus erythematosus	0.000657	0.0247	CbGeAlD
Celecoxib—PDPK1—lung—systemic lupus erythematosus	0.000625	0.0235	CbGeAlD
Celecoxib—PDPK1—nervous system—systemic lupus erythematosus	0.000579	0.0217	CbGeAlD
Celecoxib—PDPK1—central nervous system—systemic lupus erythematosus	0.000557	0.0209	CbGeAlD
Celecoxib—MAPK14—connective tissue—systemic lupus erythematosus	0.000554	0.0208	CbGeAlD
Celecoxib—ABCC4—blood plasma—systemic lupus erythematosus	0.000532	0.02	CbGeAlD
Celecoxib—CYP3A4—urine—systemic lupus erythematosus	0.000501	0.0188	CbGeAlD
Celecoxib—MAPK14—skin of body—systemic lupus erythematosus	0.0005	0.0188	CbGeAlD
Celecoxib—CYP2D6—urine—systemic lupus erythematosus	0.000493	0.0185	CbGeAlD
Celecoxib—MAPK14—kidney—systemic lupus erythematosus	0.000472	0.0177	CbGeAlD
Celecoxib—CA12—connective tissue—systemic lupus erythematosus	0.00042	0.0158	CbGeAlD
Celecoxib—CA2—blood plasma—systemic lupus erythematosus	0.000405	0.0152	CbGeAlD
Celecoxib—MAPK14—lymphoid tissue—systemic lupus erythematosus	0.000405	0.0152	CbGeAlD
Celecoxib—CA9—tendon—systemic lupus erythematosus	0.000391	0.0147	CbGeAlD
Celecoxib—MAPK14—tendon—systemic lupus erythematosus	0.000381	0.0143	CbGeAlD
Celecoxib—CA14—tendon—systemic lupus erythematosus	0.00037	0.0139	CbGeAlD
Celecoxib—MAPK14—bone marrow—systemic lupus erythematosus	0.000369	0.0139	CbGeAlD
Celecoxib—CA12—kidney—systemic lupus erythematosus	0.000358	0.0134	CbGeAlD
Celecoxib—CYP2C9—blood plasma—systemic lupus erythematosus	0.000343	0.0129	CbGeAlD
Celecoxib—PTGS2—endothelium—systemic lupus erythematosus	0.000337	0.0127	CbGeAlD
Celecoxib—MAPK14—lung—systemic lupus erythematosus	0.000334	0.0126	CbGeAlD
Celecoxib—MAPK14—nervous system—systemic lupus erythematosus	0.000309	0.0116	CbGeAlD
Celecoxib—PTGS2—blood plasma—systemic lupus erythematosus	0.000299	0.0112	CbGeAlD
Celecoxib—MAPK14—central nervous system—systemic lupus erythematosus	0.000298	0.0112	CbGeAlD
Celecoxib—ABCC4—nephron tubule—systemic lupus erythematosus	0.000274	0.0103	CbGeAlD
Celecoxib—CYP3A4—blood plasma—systemic lupus erythematosus	0.000262	0.00982	CbGeAlD
Celecoxib—CA5B—tendon—systemic lupus erythematosus	0.000259	0.00974	CbGeAlD
Celecoxib—CYP2D6—blood plasma—systemic lupus erythematosus	0.000257	0.00967	CbGeAlD
Celecoxib—CA12—lung—systemic lupus erythematosus	0.000254	0.00953	CbGeAlD
Celecoxib—CA4—nephron tubule—systemic lupus erythematosus	0.000252	0.00947	CbGeAlD
Celecoxib—ABCC4—kidney—systemic lupus erythematosus	0.000241	0.00905	CbGeAlD
Celecoxib—CA12—nervous system—systemic lupus erythematosus	0.000235	0.00882	CbGeAlD
Celecoxib—ABCC4—cortex of kidney—systemic lupus erythematosus	0.000235	0.00882	CbGeAlD
Celecoxib—CA5B—lung—systemic lupus erythematosus	0.000227	0.00854	CbGeAlD
Celecoxib—CA12—central nervous system—systemic lupus erythematosus	0.000226	0.00849	CbGeAlD
Celecoxib—ORM1—bone marrow—systemic lupus erythematosus	0.000222	0.00834	CbGeAlD
Celecoxib—CA4—kidney—systemic lupus erythematosus	0.000222	0.00832	CbGeAlD
Celecoxib—CA2—connective tissue—systemic lupus erythematosus	0.000216	0.00811	CbGeAlD
Celecoxib—CA4—cortex of kidney—systemic lupus erythematosus	0.000216	0.00811	CbGeAlD
Celecoxib—Etoricoxib—PTGS2—systemic lupus erythematosus	0.000215	1	CrCbGaD
Celecoxib—CA5B—nervous system—systemic lupus erythematosus	0.000211	0.00791	CbGeAlD
Celecoxib—CA2—nephron tubule—systemic lupus erythematosus	0.000209	0.00785	CbGeAlD
Celecoxib—CA5B—central nervous system—systemic lupus erythematosus	0.000203	0.00762	CbGeAlD
Celecoxib—ORM1—lung—systemic lupus erythematosus	0.000201	0.00756	CbGeAlD
Celecoxib—CA2—skin of body—systemic lupus erythematosus	0.000195	0.00732	CbGeAlD
Celecoxib—ABCC4—tendon—systemic lupus erythematosus	0.000195	0.00731	CbGeAlD
Celecoxib—ABCC4—bone marrow—systemic lupus erythematosus	0.000189	0.00708	CbGeAlD
Celecoxib—ORM1—nervous system—systemic lupus erythematosus	0.000186	0.007	CbGeAlD
Celecoxib—CA2—kidney—systemic lupus erythematosus	0.000184	0.0069	CbGeAlD
Celecoxib—PTGS2—Fluocinonide—Methylprednisolone—systemic lupus erythematosus	0.000181	0.159	CbGdCrCtD
Celecoxib—ORM1—central nervous system—systemic lupus erythematosus	0.000179	0.00674	CbGeAlD
Celecoxib—CA2—cortex of kidney—systemic lupus erythematosus	0.000179	0.00672	CbGeAlD
Celecoxib—CA4—tendon—systemic lupus erythematosus	0.000179	0.00672	CbGeAlD
Celecoxib—PTGS2—Fluocinonide—Dexamethasone—systemic lupus erythematosus	0.000178	0.156	CbGdCrCtD
Celecoxib—PTGS2—Fluocinonide—Betamethasone—systemic lupus erythematosus	0.000178	0.156	CbGdCrCtD
Celecoxib—PTGS2—Fluocinonide—Triamcinolone—systemic lupus erythematosus	0.000174	0.153	CbGdCrCtD
Celecoxib—CA4—bone marrow—systemic lupus erythematosus	0.000173	0.00651	CbGeAlD
Celecoxib—ABCC4—lung—systemic lupus erythematosus	0.000171	0.00642	CbGeAlD
Celecoxib—PTGS2—connective tissue—systemic lupus erythematosus	0.000159	0.00599	CbGeAlD
Celecoxib—ABCC4—nervous system—systemic lupus erythematosus	0.000158	0.00594	CbGeAlD
Celecoxib—CA2—lymphoid tissue—systemic lupus erythematosus	0.000158	0.00593	CbGeAlD
Celecoxib—CA4—lung—systemic lupus erythematosus	0.000157	0.0059	CbGeAlD
Celecoxib—ABCC4—central nervous system—systemic lupus erythematosus	0.000152	0.00572	CbGeAlD
Celecoxib—CA2—tendon—systemic lupus erythematosus	0.000148	0.00557	CbGeAlD
Celecoxib—CA4—nervous system—systemic lupus erythematosus	0.000145	0.00546	CbGeAlD
Celecoxib—PTGS2—skin of body—systemic lupus erythematosus	0.000144	0.0054	CbGeAlD
Celecoxib—CA2—bone marrow—systemic lupus erythematosus	0.000144	0.0054	CbGeAlD
Celecoxib—CA4—central nervous system—systemic lupus erythematosus	0.00014	0.00526	CbGeAlD
Celecoxib—PTGS2—kidney—systemic lupus erythematosus	0.000136	0.0051	CbGeAlD
Celecoxib—CA2—lung—systemic lupus erythematosus	0.00013	0.00489	CbGeAlD
Celecoxib—CA2—nervous system—systemic lupus erythematosus	0.000121	0.00453	CbGeAlD
Celecoxib—CYP3A4—kidney—systemic lupus erythematosus	0.000119	0.00445	CbGeAlD
Celecoxib—CYP2D6—kidney—systemic lupus erythematosus	0.000117	0.00438	CbGeAlD
Celecoxib—PTGS2—lymphoid tissue—systemic lupus erythematosus	0.000116	0.00438	CbGeAlD
Celecoxib—CA2—central nervous system—systemic lupus erythematosus	0.000116	0.00436	CbGeAlD
Celecoxib—PTGS2—tendon—systemic lupus erythematosus	0.00011	0.00411	CbGeAlD
Celecoxib—PTGS2—Fluticasone Propionate—Methylprednisolone—systemic lupus erythematosus	0.000109	0.0958	CbGdCrCtD
Celecoxib—PTGS2—Fluticasone Propionate—Betamethasone—systemic lupus erythematosus	0.000108	0.0942	CbGdCrCtD
Celecoxib—PTGS2—Fluticasone Propionate—Dexamethasone—systemic lupus erythematosus	0.000108	0.0942	CbGdCrCtD
Celecoxib—PTGS2—bone marrow—systemic lupus erythematosus	0.000106	0.00399	CbGeAlD
Celecoxib—PTGS2—Fluticasone Propionate—Triamcinolone—systemic lupus erythematosus	0.000105	0.0921	CbGdCrCtD
Celecoxib—PTGS2—lung—systemic lupus erythematosus	9.61e-05	0.00361	CbGeAlD
Celecoxib—PTGS2—nervous system—systemic lupus erythematosus	8.9e-05	0.00334	CbGeAlD
Celecoxib—PTGS2—central nervous system—systemic lupus erythematosus	8.57e-05	0.00322	CbGeAlD
Celecoxib—CYP3A4—nervous system—systemic lupus erythematosus	7.78e-05	0.00292	CbGeAlD
Celecoxib—CYP2D6—nervous system—systemic lupus erythematosus	7.65e-05	0.00288	CbGeAlD
Celecoxib—CYP3A4—central nervous system—systemic lupus erythematosus	7.49e-05	0.00281	CbGeAlD
Celecoxib—CYP2D6—central nervous system—systemic lupus erythematosus	7.37e-05	0.00277	CbGeAlD
Celecoxib—Anxiety—Betamethasone—systemic lupus erythematosus	2.64e-05	0.00034	CcSEcCtD
Celecoxib—Anxiety—Dexamethasone—systemic lupus erythematosus	2.64e-05	0.00034	CcSEcCtD
Celecoxib—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	2.62e-05	0.000337	CcSEcCtD
Celecoxib—Haemoglobin—Methotrexate—systemic lupus erythematosus	2.61e-05	0.000337	CcSEcCtD
Celecoxib—Hepatitis—Methotrexate—systemic lupus erythematosus	2.6e-05	0.000335	CcSEcCtD
Celecoxib—Haemorrhage—Methotrexate—systemic lupus erythematosus	2.6e-05	0.000335	CcSEcCtD
Celecoxib—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	2.59e-05	0.000334	CcSEcCtD
Celecoxib—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	2.58e-05	0.000333	CcSEcCtD
Celecoxib—Pharyngitis—Methotrexate—systemic lupus erythematosus	2.58e-05	0.000333	CcSEcCtD
Celecoxib—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	2.58e-05	0.000332	CcSEcCtD
Celecoxib—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	2.58e-05	0.000332	CcSEcCtD
Celecoxib—Nausea—Leflunomide—systemic lupus erythematosus	2.57e-05	0.000332	CcSEcCtD
Celecoxib—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	2.57e-05	0.000331	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	2.57e-05	0.000331	CcSEcCtD
Celecoxib—Fatigue—Hydrocortisone—systemic lupus erythematosus	2.56e-05	0.00033	CcSEcCtD
Celecoxib—Vision blurred—Prednisone—systemic lupus erythematosus	2.55e-05	0.000329	CcSEcCtD
Celecoxib—Urethral disorder—Methotrexate—systemic lupus erythematosus	2.55e-05	0.000329	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	2.55e-05	0.000329	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	2.54e-05	0.000328	CcSEcCtD
Celecoxib—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	2.54e-05	0.000327	CcSEcCtD
Celecoxib—Oedema—Betamethasone—systemic lupus erythematosus	2.54e-05	0.000327	CcSEcCtD
Celecoxib—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	2.54e-05	0.000327	CcSEcCtD
Celecoxib—Oedema—Dexamethasone—systemic lupus erythematosus	2.54e-05	0.000327	CcSEcCtD
Celecoxib—Insomnia—Triamcinolone—systemic lupus erythematosus	2.53e-05	0.000326	CcSEcCtD
Celecoxib—Insomnia—Methylprednisolone—systemic lupus erythematosus	2.53e-05	0.000325	CcSEcCtD
Celecoxib—Infection—Dexamethasone—systemic lupus erythematosus	2.52e-05	0.000325	CcSEcCtD
Celecoxib—Infection—Betamethasone—systemic lupus erythematosus	2.52e-05	0.000325	CcSEcCtD
Celecoxib—Paraesthesia—Triamcinolone—systemic lupus erythematosus	2.51e-05	0.000324	CcSEcCtD
Celecoxib—Feeling abnormal—Prednisolone—systemic lupus erythematosus	2.51e-05	0.000323	CcSEcCtD
Celecoxib—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	2.51e-05	0.000323	CcSEcCtD
Celecoxib—Anaemia—Prednisone—systemic lupus erythematosus	2.5e-05	0.000323	CcSEcCtD
Celecoxib—Shock—Dexamethasone—systemic lupus erythematosus	2.5e-05	0.000322	CcSEcCtD
Celecoxib—Shock—Betamethasone—systemic lupus erythematosus	2.5e-05	0.000322	CcSEcCtD
Celecoxib—Dyspnoea—Triamcinolone—systemic lupus erythematosus	2.49e-05	0.000321	CcSEcCtD
Celecoxib—Nervous system disorder—Betamethasone—systemic lupus erythematosus	2.49e-05	0.000321	CcSEcCtD
Celecoxib—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	2.49e-05	0.000321	CcSEcCtD
Celecoxib—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	2.49e-05	0.00032	CcSEcCtD
Celecoxib—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	2.49e-05	0.00032	CcSEcCtD
Celecoxib—Tachycardia—Betamethasone—systemic lupus erythematosus	2.48e-05	0.000319	CcSEcCtD
Celecoxib—Tachycardia—Dexamethasone—systemic lupus erythematosus	2.48e-05	0.000319	CcSEcCtD
Celecoxib—Angioedema—Prednisone—systemic lupus erythematosus	2.48e-05	0.000319	CcSEcCtD
Celecoxib—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	2.46e-05	0.000317	CcSEcCtD
Celecoxib—Dyspepsia—Triamcinolone—systemic lupus erythematosus	2.46e-05	0.000317	CcSEcCtD
Celecoxib—Erythema multiforme—Methotrexate—systemic lupus erythematosus	2.46e-05	0.000317	CcSEcCtD
Celecoxib—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	2.46e-05	0.000317	CcSEcCtD
Celecoxib—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	2.45e-05	0.000316	CcSEcCtD
Celecoxib—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	2.45e-05	0.000316	CcSEcCtD
Celecoxib—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	2.45e-05	0.000316	CcSEcCtD
Celecoxib—Vertigo—Prednisone—systemic lupus erythematosus	2.43e-05	0.000314	CcSEcCtD
Celecoxib—Eye disorder—Methotrexate—systemic lupus erythematosus	2.43e-05	0.000313	CcSEcCtD
Celecoxib—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	2.43e-05	0.000313	CcSEcCtD
Celecoxib—Syncope—Prednisone—systemic lupus erythematosus	2.43e-05	0.000313	CcSEcCtD
Celecoxib—Tinnitus—Methotrexate—systemic lupus erythematosus	2.43e-05	0.000313	CcSEcCtD
Celecoxib—Anorexia—Dexamethasone—systemic lupus erythematosus	2.42e-05	0.000312	CcSEcCtD
Celecoxib—Anorexia—Betamethasone—systemic lupus erythematosus	2.42e-05	0.000312	CcSEcCtD
Celecoxib—Urticaria—Prednisolone—systemic lupus erythematosus	2.42e-05	0.000312	CcSEcCtD
Celecoxib—Cardiac disorder—Methotrexate—systemic lupus erythematosus	2.41e-05	0.000311	CcSEcCtD
Celecoxib—Fatigue—Triamcinolone—systemic lupus erythematosus	2.41e-05	0.000311	CcSEcCtD
Celecoxib—Fatigue—Methylprednisolone—systemic lupus erythematosus	2.41e-05	0.00031	CcSEcCtD
Celecoxib—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	2.4e-05	0.00031	CcSEcCtD
Celecoxib—Asthenia—Cyclosporine—systemic lupus erythematosus	2.4e-05	0.000309	CcSEcCtD
Celecoxib—Loss of consciousness—Prednisone—systemic lupus erythematosus	2.38e-05	0.000307	CcSEcCtD
Celecoxib—Pruritus—Cyclosporine—systemic lupus erythematosus	2.37e-05	0.000305	CcSEcCtD
Celecoxib—Urticaria—Hydrocortisone—systemic lupus erythematosus	2.36e-05	0.000304	CcSEcCtD
Celecoxib—Angiopathy—Methotrexate—systemic lupus erythematosus	2.36e-05	0.000304	CcSEcCtD
Celecoxib—Immune system disorder—Methotrexate—systemic lupus erythematosus	2.35e-05	0.000303	CcSEcCtD
Celecoxib—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	2.35e-05	0.000303	CcSEcCtD
Celecoxib—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	2.35e-05	0.000303	CcSEcCtD
Celecoxib—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	2.34e-05	0.000302	CcSEcCtD
Celecoxib—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	2.34e-05	0.000302	CcSEcCtD
Celecoxib—Hypertension—Prednisone—systemic lupus erythematosus	2.34e-05	0.000301	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	2.31e-05	0.000298	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	2.31e-05	0.000298	CcSEcCtD
Celecoxib—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	2.31e-05	0.000297	CcSEcCtD
Celecoxib—Arthralgia—Prednisone—systemic lupus erythematosus	2.31e-05	0.000297	CcSEcCtD
Celecoxib—Myalgia—Prednisone—systemic lupus erythematosus	2.31e-05	0.000297	CcSEcCtD
Celecoxib—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	2.31e-05	0.000297	CcSEcCtD
Celecoxib—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	2.3e-05	0.000296	CcSEcCtD
Celecoxib—Anxiety—Prednisone—systemic lupus erythematosus	2.3e-05	0.000296	CcSEcCtD
Celecoxib—Alopecia—Methotrexate—systemic lupus erythematosus	2.3e-05	0.000296	CcSEcCtD
Celecoxib—Insomnia—Dexamethasone—systemic lupus erythematosus	2.3e-05	0.000296	CcSEcCtD
Celecoxib—Insomnia—Betamethasone—systemic lupus erythematosus	2.3e-05	0.000296	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	2.29e-05	0.000295	CcSEcCtD
Celecoxib—Diarrhoea—Cyclosporine—systemic lupus erythematosus	2.29e-05	0.000295	CcSEcCtD
Celecoxib—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	2.28e-05	0.000294	CcSEcCtD
Celecoxib—Paraesthesia—Dexamethasone—systemic lupus erythematosus	2.28e-05	0.000294	CcSEcCtD
Celecoxib—Paraesthesia—Betamethasone—systemic lupus erythematosus	2.28e-05	0.000294	CcSEcCtD
Celecoxib—Mental disorder—Methotrexate—systemic lupus erythematosus	2.28e-05	0.000294	CcSEcCtD
Celecoxib—Hypersensitivity—Prednisolone—systemic lupus erythematosus	2.24e-05	0.000289	CcSEcCtD
Celecoxib—Dyspepsia—Betamethasone—systemic lupus erythematosus	2.23e-05	0.000288	CcSEcCtD
Celecoxib—Dyspepsia—Dexamethasone—systemic lupus erythematosus	2.23e-05	0.000288	CcSEcCtD
Celecoxib—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	2.23e-05	0.000288	CcSEcCtD
Celecoxib—Urticaria—Triamcinolone—systemic lupus erythematosus	2.22e-05	0.000286	CcSEcCtD
Celecoxib—Urticaria—Methylprednisolone—systemic lupus erythematosus	2.22e-05	0.000286	CcSEcCtD
Celecoxib—Dysgeusia—Methotrexate—systemic lupus erythematosus	2.22e-05	0.000286	CcSEcCtD
Celecoxib—Body temperature increased—Triamcinolone—systemic lupus erythematosus	2.21e-05	0.000285	CcSEcCtD
Celecoxib—Dizziness—Cyclosporine—systemic lupus erythematosus	2.21e-05	0.000285	CcSEcCtD
Celecoxib—Oedema—Prednisone—systemic lupus erythematosus	2.21e-05	0.000285	CcSEcCtD
Celecoxib—Anaphylactic shock—Prednisone—systemic lupus erythematosus	2.21e-05	0.000285	CcSEcCtD
Celecoxib—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	2.21e-05	0.000284	CcSEcCtD
Celecoxib—Decreased appetite—Dexamethasone—systemic lupus erythematosus	2.21e-05	0.000284	CcSEcCtD
Celecoxib—Decreased appetite—Betamethasone—systemic lupus erythematosus	2.21e-05	0.000284	CcSEcCtD
Celecoxib—Infection—Prednisone—systemic lupus erythematosus	2.2e-05	0.000283	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	2.19e-05	0.000282	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	2.19e-05	0.000282	CcSEcCtD
Celecoxib—Back pain—Methotrexate—systemic lupus erythematosus	2.19e-05	0.000282	CcSEcCtD
Celecoxib—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	2.19e-05	0.000282	CcSEcCtD
Celecoxib—Fatigue—Betamethasone—systemic lupus erythematosus	2.19e-05	0.000282	CcSEcCtD
Celecoxib—Fatigue—Dexamethasone—systemic lupus erythematosus	2.19e-05	0.000282	CcSEcCtD
Celecoxib—Shock—Prednisone—systemic lupus erythematosus	2.18e-05	0.00028	CcSEcCtD
Celecoxib—Nervous system disorder—Prednisone—systemic lupus erythematosus	2.17e-05	0.000279	CcSEcCtD
Celecoxib—Tachycardia—Prednisone—systemic lupus erythematosus	2.16e-05	0.000278	CcSEcCtD
Celecoxib—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	2.16e-05	0.000278	CcSEcCtD
Celecoxib—Skin disorder—Prednisone—systemic lupus erythematosus	2.15e-05	0.000277	CcSEcCtD
Celecoxib—Hyperhidrosis—Prednisone—systemic lupus erythematosus	2.14e-05	0.000275	CcSEcCtD
Celecoxib—Vision blurred—Methotrexate—systemic lupus erythematosus	2.13e-05	0.000275	CcSEcCtD
Celecoxib—Asthenia—Hydrocortisone—systemic lupus erythematosus	2.13e-05	0.000275	CcSEcCtD
Celecoxib—Vomiting—Cyclosporine—systemic lupus erythematosus	2.13e-05	0.000274	CcSEcCtD
Celecoxib—Rash—Cyclosporine—systemic lupus erythematosus	2.11e-05	0.000272	CcSEcCtD
Celecoxib—Anorexia—Prednisone—systemic lupus erythematosus	2.11e-05	0.000272	CcSEcCtD
Celecoxib—Dermatitis—Cyclosporine—systemic lupus erythematosus	2.11e-05	0.000271	CcSEcCtD
Celecoxib—Pruritus—Hydrocortisone—systemic lupus erythematosus	2.1e-05	0.000271	CcSEcCtD
Celecoxib—Headache—Cyclosporine—systemic lupus erythematosus	2.09e-05	0.00027	CcSEcCtD
Celecoxib—Anaemia—Methotrexate—systemic lupus erythematosus	2.09e-05	0.00027	CcSEcCtD
Celecoxib—Feeling abnormal—Betamethasone—systemic lupus erythematosus	2.09e-05	0.00027	CcSEcCtD
Celecoxib—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	2.09e-05	0.00027	CcSEcCtD
Celecoxib—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	2.08e-05	0.000268	CcSEcCtD
Celecoxib—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	2.08e-05	0.000268	CcSEcCtD
Celecoxib—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	2.07e-05	0.000267	CcSEcCtD
Celecoxib—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	2.06e-05	0.000266	CcSEcCtD
Celecoxib—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	2.06e-05	0.000265	CcSEcCtD
Celecoxib—Rash—Mycophenolate mofetil—systemic lupus erythematosus	2.06e-05	0.000265	CcSEcCtD
Celecoxib—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	2.05e-05	0.000265	CcSEcCtD
Celecoxib—Headache—Mycophenolate mofetil—systemic lupus erythematosus	2.04e-05	0.000263	CcSEcCtD
Celecoxib—Vertigo—Methotrexate—systemic lupus erythematosus	2.03e-05	0.000262	CcSEcCtD
Celecoxib—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	2.03e-05	0.000262	CcSEcCtD
Celecoxib—Leukopenia—Methotrexate—systemic lupus erythematosus	2.03e-05	0.000261	CcSEcCtD
Celecoxib—Urticaria—Betamethasone—systemic lupus erythematosus	2.02e-05	0.00026	CcSEcCtD
Celecoxib—Urticaria—Dexamethasone—systemic lupus erythematosus	2.02e-05	0.00026	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	2.01e-05	0.00026	CcSEcCtD
Celecoxib—Dizziness—Prednisolone—systemic lupus erythematosus	2.01e-05	0.000259	CcSEcCtD
Celecoxib—Asthenia—Triamcinolone—systemic lupus erythematosus	2.01e-05	0.000259	CcSEcCtD
Celecoxib—Abdominal pain—Betamethasone—systemic lupus erythematosus	2.01e-05	0.000259	CcSEcCtD
Celecoxib—Abdominal pain—Dexamethasone—systemic lupus erythematosus	2.01e-05	0.000259	CcSEcCtD
Celecoxib—Body temperature increased—Dexamethasone—systemic lupus erythematosus	2.01e-05	0.000259	CcSEcCtD
Celecoxib—Body temperature increased—Betamethasone—systemic lupus erythematosus	2.01e-05	0.000259	CcSEcCtD
Celecoxib—Asthenia—Methylprednisolone—systemic lupus erythematosus	2e-05	0.000258	CcSEcCtD
Celecoxib—Insomnia—Prednisone—systemic lupus erythematosus	2e-05	0.000258	CcSEcCtD
Celecoxib—Nausea—Cyclosporine—systemic lupus erythematosus	1.99e-05	0.000256	CcSEcCtD
Celecoxib—Paraesthesia—Prednisone—systemic lupus erythematosus	1.99e-05	0.000256	CcSEcCtD
Celecoxib—Pruritus—Triamcinolone—systemic lupus erythematosus	1.98e-05	0.000255	CcSEcCtD
Celecoxib—Cough—Methotrexate—systemic lupus erythematosus	1.98e-05	0.000255	CcSEcCtD
Celecoxib—Pruritus—Methylprednisolone—systemic lupus erythematosus	1.98e-05	0.000255	CcSEcCtD
Celecoxib—Dizziness—Hydrocortisone—systemic lupus erythematosus	1.97e-05	0.000253	CcSEcCtD
Celecoxib—Dyspepsia—Prednisone—systemic lupus erythematosus	1.95e-05	0.000251	CcSEcCtD
Celecoxib—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	1.94e-05	0.00025	CcSEcCtD
Celecoxib—Chest pain—Methotrexate—systemic lupus erythematosus	1.93e-05	0.000248	CcSEcCtD
Celecoxib—Myalgia—Methotrexate—systemic lupus erythematosus	1.93e-05	0.000248	CcSEcCtD
Celecoxib—Arthralgia—Methotrexate—systemic lupus erythematosus	1.93e-05	0.000248	CcSEcCtD
Celecoxib—Decreased appetite—Prednisone—systemic lupus erythematosus	1.92e-05	0.000248	CcSEcCtD
Celecoxib—Rash—Prednisolone—systemic lupus erythematosus	1.92e-05	0.000247	CcSEcCtD
Celecoxib—Dermatitis—Prednisolone—systemic lupus erythematosus	1.92e-05	0.000247	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	1.91e-05	0.000247	CcSEcCtD
Celecoxib—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	1.91e-05	0.000246	CcSEcCtD
Celecoxib—Fatigue—Prednisone—systemic lupus erythematosus	1.91e-05	0.000246	CcSEcCtD
Celecoxib—Headache—Prednisolone—systemic lupus erythematosus	1.91e-05	0.000246	CcSEcCtD
Celecoxib—Constipation—Prednisone—systemic lupus erythematosus	1.89e-05	0.000244	CcSEcCtD
Celecoxib—Vomiting—Hydrocortisone—systemic lupus erythematosus	1.89e-05	0.000243	CcSEcCtD
Celecoxib—Rash—Hydrocortisone—systemic lupus erythematosus	1.87e-05	0.000241	CcSEcCtD
Celecoxib—Dermatitis—Hydrocortisone—systemic lupus erythematosus	1.87e-05	0.000241	CcSEcCtD
Celecoxib—Confusional state—Methotrexate—systemic lupus erythematosus	1.86e-05	0.00024	CcSEcCtD
Celecoxib—Headache—Hydrocortisone—systemic lupus erythematosus	1.86e-05	0.00024	CcSEcCtD
Celecoxib—Dizziness—Triamcinolone—systemic lupus erythematosus	1.85e-05	0.000238	CcSEcCtD
Celecoxib—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	1.85e-05	0.000238	CcSEcCtD
Celecoxib—Dizziness—Methylprednisolone—systemic lupus erythematosus	1.85e-05	0.000238	CcSEcCtD
Celecoxib—Infection—Methotrexate—systemic lupus erythematosus	1.84e-05	0.000237	CcSEcCtD
Celecoxib—Feeling abnormal—Prednisone—systemic lupus erythematosus	1.82e-05	0.000235	CcSEcCtD
Celecoxib—Asthenia—Betamethasone—systemic lupus erythematosus	1.82e-05	0.000235	CcSEcCtD
Celecoxib—Asthenia—Dexamethasone—systemic lupus erythematosus	1.82e-05	0.000235	CcSEcCtD
Celecoxib—Nervous system disorder—Methotrexate—systemic lupus erythematosus	1.81e-05	0.000234	CcSEcCtD
Celecoxib—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	1.81e-05	0.000233	CcSEcCtD
Celecoxib—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	1.81e-05	0.000233	CcSEcCtD
Celecoxib—Nausea—Prednisolone—systemic lupus erythematosus	1.81e-05	0.000233	CcSEcCtD
Celecoxib—Pruritus—Dexamethasone—systemic lupus erythematosus	1.8e-05	0.000231	CcSEcCtD
Celecoxib—Pruritus—Betamethasone—systemic lupus erythematosus	1.8e-05	0.000231	CcSEcCtD
Celecoxib—Skin disorder—Methotrexate—systemic lupus erythematosus	1.79e-05	0.000231	CcSEcCtD
Celecoxib—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	1.79e-05	0.00023	CcSEcCtD
Celecoxib—Vomiting—Triamcinolone—systemic lupus erythematosus	1.78e-05	0.000229	CcSEcCtD
Celecoxib—Vomiting—Methylprednisolone—systemic lupus erythematosus	1.78e-05	0.000229	CcSEcCtD
Celecoxib—Nausea—Hydrocortisone—systemic lupus erythematosus	1.77e-05	0.000227	CcSEcCtD
Celecoxib—Rash—Triamcinolone—systemic lupus erythematosus	1.76e-05	0.000227	CcSEcCtD
Celecoxib—Dermatitis—Triamcinolone—systemic lupus erythematosus	1.76e-05	0.000227	CcSEcCtD
Celecoxib—Anorexia—Methotrexate—systemic lupus erythematosus	1.76e-05	0.000227	CcSEcCtD
Celecoxib—Rash—Methylprednisolone—systemic lupus erythematosus	1.76e-05	0.000227	CcSEcCtD
Celecoxib—Dermatitis—Methylprednisolone—systemic lupus erythematosus	1.76e-05	0.000227	CcSEcCtD
Celecoxib—Urticaria—Prednisone—systemic lupus erythematosus	1.76e-05	0.000226	CcSEcCtD
Celecoxib—Headache—Triamcinolone—systemic lupus erythematosus	1.75e-05	0.000226	CcSEcCtD
Celecoxib—Headache—Methylprednisolone—systemic lupus erythematosus	1.75e-05	0.000225	CcSEcCtD
Celecoxib—Abdominal pain—Prednisone—systemic lupus erythematosus	1.75e-05	0.000225	CcSEcCtD
Celecoxib—Body temperature increased—Prednisone—systemic lupus erythematosus	1.75e-05	0.000225	CcSEcCtD
Celecoxib—Diarrhoea—Dexamethasone—systemic lupus erythematosus	1.74e-05	0.000224	CcSEcCtD
Celecoxib—Diarrhoea—Betamethasone—systemic lupus erythematosus	1.74e-05	0.000224	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	1.68e-05	0.000217	CcSEcCtD
Celecoxib—Dizziness—Betamethasone—systemic lupus erythematosus	1.68e-05	0.000216	CcSEcCtD
Celecoxib—Dizziness—Dexamethasone—systemic lupus erythematosus	1.68e-05	0.000216	CcSEcCtD
Celecoxib—Insomnia—Methotrexate—systemic lupus erythematosus	1.67e-05	0.000215	CcSEcCtD
Celecoxib—Nausea—Triamcinolone—systemic lupus erythematosus	1.66e-05	0.000214	CcSEcCtD
Celecoxib—Paraesthesia—Methotrexate—systemic lupus erythematosus	1.66e-05	0.000214	CcSEcCtD
Celecoxib—Nausea—Methylprednisolone—systemic lupus erythematosus	1.66e-05	0.000214	CcSEcCtD
Celecoxib—Dyspnoea—Methotrexate—systemic lupus erythematosus	1.65e-05	0.000212	CcSEcCtD
Celecoxib—Somnolence—Methotrexate—systemic lupus erythematosus	1.64e-05	0.000212	CcSEcCtD
Celecoxib—Hypersensitivity—Prednisone—systemic lupus erythematosus	1.63e-05	0.00021	CcSEcCtD
Celecoxib—Dyspepsia—Methotrexate—systemic lupus erythematosus	1.63e-05	0.00021	CcSEcCtD
Celecoxib—Vomiting—Betamethasone—systemic lupus erythematosus	1.61e-05	0.000208	CcSEcCtD
Celecoxib—Vomiting—Dexamethasone—systemic lupus erythematosus	1.61e-05	0.000208	CcSEcCtD
Celecoxib—Decreased appetite—Methotrexate—systemic lupus erythematosus	1.61e-05	0.000207	CcSEcCtD
Celecoxib—Rash—Dexamethasone—systemic lupus erythematosus	1.6e-05	0.000206	CcSEcCtD
Celecoxib—Rash—Betamethasone—systemic lupus erythematosus	1.6e-05	0.000206	CcSEcCtD
Celecoxib—Dermatitis—Dexamethasone—systemic lupus erythematosus	1.6e-05	0.000206	CcSEcCtD
Celecoxib—Dermatitis—Betamethasone—systemic lupus erythematosus	1.6e-05	0.000206	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	1.6e-05	0.000206	CcSEcCtD
Celecoxib—Fatigue—Methotrexate—systemic lupus erythematosus	1.59e-05	0.000205	CcSEcCtD
Celecoxib—Headache—Betamethasone—systemic lupus erythematosus	1.59e-05	0.000205	CcSEcCtD
Celecoxib—Headache—Dexamethasone—systemic lupus erythematosus	1.59e-05	0.000205	CcSEcCtD
Celecoxib—Asthenia—Prednisone—systemic lupus erythematosus	1.59e-05	0.000204	CcSEcCtD
Celecoxib—Pruritus—Prednisone—systemic lupus erythematosus	1.56e-05	0.000202	CcSEcCtD
Celecoxib—Feeling abnormal—Methotrexate—systemic lupus erythematosus	1.52e-05	0.000196	CcSEcCtD
Celecoxib—Diarrhoea—Prednisone—systemic lupus erythematosus	1.51e-05	0.000195	CcSEcCtD
Celecoxib—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	1.51e-05	0.000195	CcSEcCtD
Celecoxib—Nausea—Dexamethasone—systemic lupus erythematosus	1.51e-05	0.000194	CcSEcCtD
Celecoxib—Nausea—Betamethasone—systemic lupus erythematosus	1.51e-05	0.000194	CcSEcCtD
Celecoxib—Urticaria—Methotrexate—systemic lupus erythematosus	1.47e-05	0.000189	CcSEcCtD
Celecoxib—Dizziness—Prednisone—systemic lupus erythematosus	1.46e-05	0.000188	CcSEcCtD
Celecoxib—Body temperature increased—Methotrexate—systemic lupus erythematosus	1.46e-05	0.000188	CcSEcCtD
Celecoxib—Abdominal pain—Methotrexate—systemic lupus erythematosus	1.46e-05	0.000188	CcSEcCtD
Celecoxib—Vomiting—Prednisone—systemic lupus erythematosus	1.41e-05	0.000181	CcSEcCtD
Celecoxib—Rash—Prednisone—systemic lupus erythematosus	1.39e-05	0.00018	CcSEcCtD
Celecoxib—Dermatitis—Prednisone—systemic lupus erythematosus	1.39e-05	0.000179	CcSEcCtD
Celecoxib—Headache—Prednisone—systemic lupus erythematosus	1.39e-05	0.000179	CcSEcCtD
Celecoxib—Hypersensitivity—Methotrexate—systemic lupus erythematosus	1.36e-05	0.000175	CcSEcCtD
Celecoxib—Asthenia—Methotrexate—systemic lupus erythematosus	1.33e-05	0.000171	CcSEcCtD
Celecoxib—Nausea—Prednisone—systemic lupus erythematosus	1.31e-05	0.000169	CcSEcCtD
Celecoxib—Pruritus—Methotrexate—systemic lupus erythematosus	1.31e-05	0.000168	CcSEcCtD
Celecoxib—Diarrhoea—Methotrexate—systemic lupus erythematosus	1.26e-05	0.000163	CcSEcCtD
Celecoxib—Dizziness—Methotrexate—systemic lupus erythematosus	1.22e-05	0.000157	CcSEcCtD
Celecoxib—Vomiting—Methotrexate—systemic lupus erythematosus	1.17e-05	0.000151	CcSEcCtD
Celecoxib—Rash—Methotrexate—systemic lupus erythematosus	1.17e-05	0.00015	CcSEcCtD
Celecoxib—Dermatitis—Methotrexate—systemic lupus erythematosus	1.16e-05	0.00015	CcSEcCtD
Celecoxib—Headache—Methotrexate—systemic lupus erythematosus	1.16e-05	0.000149	CcSEcCtD
Celecoxib—Nausea—Methotrexate—systemic lupus erythematosus	1.1e-05	0.000141	CcSEcCtD
Celecoxib—CA5A—Metabolism—NOS3—systemic lupus erythematosus	7.03e-06	0.000127	CbGpPWpGaD
Celecoxib—CA6—Metabolism—NOS3—systemic lupus erythematosus	7.03e-06	0.000127	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—ALB—systemic lupus erythematosus	6.96e-06	0.000125	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—PTPRC—systemic lupus erythematosus	6.96e-06	0.000125	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL1RN—systemic lupus erythematosus	6.93e-06	0.000125	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—PPARG—systemic lupus erythematosus	6.91e-06	0.000125	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—TLR4—systemic lupus erythematosus	6.86e-06	0.000124	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—ALB—systemic lupus erythematosus	6.86e-06	0.000124	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—NOS3—systemic lupus erythematosus	6.66e-06	0.00012	CbGpPWpGaD
Celecoxib—CA14—Metabolism—PTGS2—systemic lupus erythematosus	6.6e-06	0.000119	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—NOS3—systemic lupus erythematosus	6.56e-06	0.000118	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—TYK2—systemic lupus erythematosus	6.56e-06	0.000118	CbGpPWpGaD
Celecoxib—PDPK1—Disease—CD80—systemic lupus erythematosus	6.55e-06	0.000118	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TLR9—systemic lupus erythematosus	6.49e-06	0.000117	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	6.49e-06	0.000117	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD40—systemic lupus erythematosus	6.47e-06	0.000117	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—IL6—systemic lupus erythematosus	6.47e-06	0.000117	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—PTGS2—systemic lupus erythematosus	6.43e-06	0.000116	CbGpPWpGaD
Celecoxib—CA6—Metabolism—PTGS2—systemic lupus erythematosus	6.43e-06	0.000116	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—JUNB—systemic lupus erythematosus	6.39e-06	0.000115	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HMGB1—systemic lupus erythematosus	6.38e-06	0.000115	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CTLA4—systemic lupus erythematosus	6.38e-06	0.000115	CbGpPWpGaD
Celecoxib—CA12—Metabolism—ALB—systemic lupus erythematosus	6.35e-06	0.000115	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—CD80—systemic lupus erythematosus	6.33e-06	0.000114	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—P2RY12—systemic lupus erythematosus	6.29e-06	0.000113	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IFNA1—systemic lupus erythematosus	6.27e-06	0.000113	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	6.24e-06	0.000113	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—IFNA1—systemic lupus erythematosus	6.18e-06	0.000111	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	6.18e-06	0.000111	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—RASGRP1—systemic lupus erythematosus	6.1e-06	0.00011	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—ALB—systemic lupus erythematosus	6.09e-06	0.00011	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	6.08e-06	0.00011	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD79A—systemic lupus erythematosus	6.08e-06	0.00011	CbGpPWpGaD
Celecoxib—CA12—Metabolism—NOS3—systemic lupus erythematosus	6.08e-06	0.00011	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—TYK2—systemic lupus erythematosus	6.05e-06	0.000109	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	6.03e-06	0.000109	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—RASGRP1—systemic lupus erythematosus	6.02e-06	0.000108	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—IL2—systemic lupus erythematosus	6.01e-06	0.000108	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—PTGS2—systemic lupus erythematosus	6e-06	0.000108	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—TYK2—systemic lupus erythematosus	5.99e-06	0.000108	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—IL6—systemic lupus erythematosus	5.96e-06	0.000107	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—IL6—systemic lupus erythematosus	5.95e-06	0.000107	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	5.94e-06	0.000107	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—PRL—systemic lupus erythematosus	5.92e-06	0.000107	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—JAK1—systemic lupus erythematosus	5.89e-06	0.000106	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	5.85e-06	0.000105	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—NOS3—systemic lupus erythematosus	5.83e-06	0.000105	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CSK—systemic lupus erythematosus	5.79e-06	0.000104	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—IL2—systemic lupus erythematosus	5.64e-06	0.000102	CbGpPWpGaD
Celecoxib—CA4—Metabolism—PPARG—systemic lupus erythematosus	5.64e-06	0.000102	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HLA-DQA1—systemic lupus erythematosus	5.61e-06	0.000101	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IFNG—systemic lupus erythematosus	5.61e-06	0.000101	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—RXRA—systemic lupus erythematosus	5.6e-06	0.000101	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CCR5—systemic lupus erythematosus	5.58e-06	0.000101	CbGpPWpGaD
Celecoxib—CA12—Metabolism—PTGS2—systemic lupus erythematosus	5.56e-06	0.0001	CbGpPWpGaD
Celecoxib—PDPK1—Disease—TYK2—systemic lupus erythematosus	5.53e-06	9.97e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL2RA—systemic lupus erythematosus	5.5e-06	9.91e-05	CbGpPWpGaD
Celecoxib—CA14—Metabolism—EP300—systemic lupus erythematosus	5.49e-06	9.89e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—IL2—systemic lupus erythematosus	5.46e-06	9.84e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—C3—systemic lupus erythematosus	5.45e-06	9.83e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—NOS3—systemic lupus erythematosus	5.43e-06	9.79e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CD4—systemic lupus erythematosus	5.42e-06	9.77e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—HIST2H2AC—systemic lupus erythematosus	5.42e-06	9.76e-05	CbGpPWpGaD
Celecoxib—CA2—Metabolism—PPARG—systemic lupus erythematosus	5.4e-06	9.74e-05	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	5.37e-06	9.68e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—TYK2—systemic lupus erythematosus	5.35e-06	9.64e-05	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—EP300—systemic lupus erythematosus	5.35e-06	9.64e-05	CbGpPWpGaD
Celecoxib—CA6—Metabolism—EP300—systemic lupus erythematosus	5.35e-06	9.64e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NCF2—systemic lupus erythematosus	5.29e-06	9.54e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CSK—systemic lupus erythematosus	5.28e-06	9.51e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—LYN—systemic lupus erythematosus	5.26e-06	9.48e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HLA-DQB1—systemic lupus erythematosus	5.25e-06	9.46e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SH2B3—systemic lupus erythematosus	5.16e-06	9.3e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CDKN1B—systemic lupus erythematosus	5.1e-06	9.18e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—VDR—systemic lupus erythematosus	5.07e-06	9.14e-05	CbGpPWpGaD
Celecoxib—CA4—Metabolism—ALB—systemic lupus erythematosus	5.07e-06	9.13e-05	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—EP300—systemic lupus erythematosus	5.06e-06	9.13e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	5.05e-06	9.1e-05	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—IL6—systemic lupus erythematosus	5.03e-06	9.07e-05	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	5.01e-06	9.04e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—CD4—systemic lupus erythematosus	5e-06	9.02e-05	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—EP300—systemic lupus erythematosus	4.99e-06	9e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL2—systemic lupus erythematosus	4.99e-06	8.99e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL18—systemic lupus erythematosus	4.98e-06	8.97e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—PTGS2—systemic lupus erythematosus	4.97e-06	8.95e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CD247—systemic lupus erythematosus	4.96e-06	8.95e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—NAT2—systemic lupus erythematosus	4.96e-06	8.94e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD40LG—systemic lupus erythematosus	4.96e-06	8.94e-05	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—IL2—systemic lupus erythematosus	4.96e-06	8.93e-05	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—IL2—systemic lupus erythematosus	4.94e-06	8.91e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD8A—systemic lupus erythematosus	4.9e-06	8.84e-05	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—IL6—systemic lupus erythematosus	4.89e-06	8.81e-05	CbGpPWpGaD
Celecoxib—CA2—Metabolism—ALB—systemic lupus erythematosus	4.86e-06	8.76e-05	CbGpPWpGaD
Celecoxib—CA4—Metabolism—NOS3—systemic lupus erythematosus	4.85e-06	8.74e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—CD4—systemic lupus erythematosus	4.84e-06	8.72e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NCF2—systemic lupus erythematosus	4.83e-06	8.7e-05	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	4.8e-06	8.66e-05	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—VEGFA—systemic lupus erythematosus	4.8e-06	8.65e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—F2—systemic lupus erythematosus	4.79e-06	8.63e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—MMP9—systemic lupus erythematosus	4.77e-06	8.59e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—JAK1—systemic lupus erythematosus	4.73e-06	8.53e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—CDKN1B—systemic lupus erythematosus	4.7e-06	8.48e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CDKN1A—systemic lupus erythematosus	4.7e-06	8.48e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—JAK1—systemic lupus erythematosus	4.67e-06	8.41e-05	CbGpPWpGaD
Celecoxib—CA2—Metabolism—NOS3—systemic lupus erythematosus	4.65e-06	8.38e-05	CbGpPWpGaD
Celecoxib—CA12—Metabolism—EP300—systemic lupus erythematosus	4.62e-06	8.33e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CD80—systemic lupus erythematosus	4.59e-06	8.27e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—IL6—systemic lupus erythematosus	4.58e-06	8.26e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—NR3C1—systemic lupus erythematosus	4.56e-06	8.22e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PPARG—systemic lupus erythematosus	4.55e-06	8.21e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—CDKN1B—systemic lupus erythematosus	4.55e-06	8.19e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—EP300—systemic lupus erythematosus	4.52e-06	8.15e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—EP300—systemic lupus erythematosus	4.47e-06	8.06e-05	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—EP300—systemic lupus erythematosus	4.43e-06	7.99e-05	CbGpPWpGaD
Celecoxib—CA4—Metabolism—PTGS2—systemic lupus erythematosus	4.43e-06	7.99e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL2RA—systemic lupus erythematosus	4.42e-06	7.97e-05	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—TGFB1—systemic lupus erythematosus	4.4e-06	7.94e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—C3—systemic lupus erythematosus	4.38e-06	7.9e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—IL2RA—systemic lupus erythematosus	4.36e-06	7.85e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—CDKN1A—systemic lupus erythematosus	4.34e-06	7.83e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—VEGFA—systemic lupus erythematosus	4.28e-06	7.72e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CCL2—systemic lupus erythematosus	4.27e-06	7.69e-05	CbGpPWpGaD
Celecoxib—CA2—Metabolism—PTGS2—systemic lupus erythematosus	4.25e-06	7.66e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CXCL12—systemic lupus erythematosus	4.23e-06	7.63e-05	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—VEGFA—systemic lupus erythematosus	4.21e-06	7.59e-05	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—VEGFA—systemic lupus erythematosus	4.2e-06	7.57e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—CDKN1A—systemic lupus erythematosus	4.2e-06	7.56e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CRP—systemic lupus erythematosus	4.17e-06	7.51e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—JUNB—systemic lupus erythematosus	4.15e-06	7.48e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	4.13e-06	7.45e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—EP300—systemic lupus erythematosus	4.13e-06	7.45e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—ALB—systemic lupus erythematosus	4.1e-06	7.38e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—NAT2—systemic lupus erythematosus	4.01e-06	7.23e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—TLR4—systemic lupus erythematosus	4e-06	7.2e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HLA-DRB1—systemic lupus erythematosus	3.99e-06	7.2e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—EP300—systemic lupus erythematosus	3.99e-06	7.2e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—RASGRP1—systemic lupus erythematosus	3.95e-06	7.11e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	3.94e-06	7.1e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—TGFB1—systemic lupus erythematosus	3.93e-06	7.08e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—NOS3—systemic lupus erythematosus	3.92e-06	7.06e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TYK2—systemic lupus erythematosus	3.87e-06	6.98e-05	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—TGFB1—systemic lupus erythematosus	3.87e-06	6.97e-05	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—TGFB1—systemic lupus erythematosus	3.85e-06	6.95e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PRL—systemic lupus erythematosus	3.83e-06	6.9e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NOS3—systemic lupus erythematosus	3.8e-06	6.85e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—F2—systemic lupus erythematosus	3.79e-06	6.84e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—JUNB—systemic lupus erythematosus	3.79e-06	6.83e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD80—systemic lupus erythematosus	3.69e-06	6.65e-05	CbGpPWpGaD
Celecoxib—CA4—Metabolism—EP300—systemic lupus erythematosus	3.69e-06	6.65e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—TNF—systemic lupus erythematosus	3.67e-06	6.61e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—TGFB1—systemic lupus erythematosus	3.59e-06	6.47e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PTGS2—systemic lupus erythematosus	3.58e-06	6.46e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	3.54e-06	6.39e-05	CbGpPWpGaD
Celecoxib—CA2—Metabolism—EP300—systemic lupus erythematosus	3.54e-06	6.37e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—PPARG—systemic lupus erythematosus	3.53e-06	6.37e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—PRL—systemic lupus erythematosus	3.49e-06	6.29e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—NAT2—systemic lupus erythematosus	3.31e-06	5.97e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.29e-06	5.94e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	3.28e-06	5.92e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL2—systemic lupus erythematosus	3.22e-06	5.81e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—IL6—systemic lupus erythematosus	3.21e-06	5.78e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	3.19e-06	5.75e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—TYK2—systemic lupus erythematosus	3.11e-06	5.61e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—JAK1—systemic lupus erythematosus	3.06e-06	5.52e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MMP9—systemic lupus erythematosus	3.05e-06	5.5e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.04e-06	5.48e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—NOS3—systemic lupus erythematosus	3.01e-06	5.43e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—EP300—systemic lupus erythematosus	2.98e-06	5.37e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—IL6—systemic lupus erythematosus	2.96e-06	5.34e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL6—systemic lupus erythematosus	2.93e-06	5.28e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IFNG—systemic lupus erythematosus	2.92e-06	5.26e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCR5—systemic lupus erythematosus	2.9e-06	5.23e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—EP300—systemic lupus erythematosus	2.89e-06	5.21e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.86e-06	5.15e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—C3—systemic lupus erythematosus	2.83e-06	5.11e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD4—systemic lupus erythematosus	2.82e-06	5.08e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—JAK1—systemic lupus erythematosus	2.79e-06	5.03e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—RXRA—systemic lupus erythematosus	2.78e-06	5.01e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.74e-06	4.94e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—IL6—systemic lupus erythematosus	2.71e-06	4.88e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CDKN1B—systemic lupus erythematosus	2.65e-06	4.77e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CCR5—systemic lupus erythematosus	2.65e-06	4.77e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—IL6—systemic lupus erythematosus	2.62e-06	4.71e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.61e-06	4.71e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL2—systemic lupus erythematosus	2.59e-06	4.67e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.58e-06	4.65e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—IL2—systemic lupus erythematosus	2.55e-06	4.6e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.51e-06	4.53e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.51e-06	4.52e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—F2—systemic lupus erythematosus	2.49e-06	4.48e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CDKN1A—systemic lupus erythematosus	2.44e-06	4.4e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CD80—systemic lupus erythematosus	2.39e-06	4.3e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	2.35e-06	4.23e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—EP300—systemic lupus erythematosus	2.33e-06	4.19e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—EP300—systemic lupus erythematosus	2.29e-06	4.13e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—RXRA—systemic lupus erythematosus	2.25e-06	4.05e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCL2—systemic lupus erythematosus	2.22e-06	4e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CD80—systemic lupus erythematosus	2.18e-06	3.92e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—VEGFA—systemic lupus erythematosus	2.17e-06	3.91e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	2.17e-06	3.9e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.09e-06	3.76e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.05e-06	3.7e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TYK2—systemic lupus erythematosus	2.01e-06	3.63e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TGFB1—systemic lupus erythematosus	1.99e-06	3.59e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NOS3—systemic lupus erythematosus	1.98e-06	3.56e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL6—systemic lupus erythematosus	1.89e-06	3.42e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—RXRA—systemic lupus erythematosus	1.86e-06	3.35e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	1.84e-06	3.32e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—TYK2—systemic lupus erythematosus	1.84e-06	3.31e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NOS3—systemic lupus erythematosus	1.8e-06	3.25e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PPARG—systemic lupus erythematosus	1.76e-06	3.16e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.71e-06	3.09e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.71e-06	3.08e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL2—systemic lupus erythematosus	1.68e-06	3.02e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CD4—systemic lupus erythematosus	1.66e-06	2.99e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MMP9—systemic lupus erythematosus	1.59e-06	2.86e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.58e-06	2.85e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ALB—systemic lupus erythematosus	1.58e-06	2.85e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CDKN1B—systemic lupus erythematosus	1.56e-06	2.82e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL6—systemic lupus erythematosus	1.52e-06	2.75e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—NOS3—systemic lupus erythematosus	1.51e-06	2.72e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—EP300—systemic lupus erythematosus	1.5e-06	2.71e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CDKN1A—systemic lupus erythematosus	1.44e-06	2.6e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.42e-06	2.57e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PPARG—systemic lupus erythematosus	1.42e-06	2.56e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—EP300—systemic lupus erythematosus	1.37e-06	2.47e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.31e-06	2.36e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—NOS3—systemic lupus erythematosus	1.22e-06	2.2e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	1.21e-06	2.19e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—TGFB1—systemic lupus erythematosus	1.19e-06	2.15e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	1.17e-06	2.11e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	1.16e-06	2.1e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—EP300—systemic lupus erythematosus	1.15e-06	2.07e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PTGS2—systemic lupus erythematosus	1.12e-06	2.01e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	1.05e-06	1.9e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	1.05e-06	1.88e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	1.01e-06	1.82e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	1e-06	1.8e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL6—systemic lupus erythematosus	9.85e-07	1.77e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—EP300—systemic lupus erythematosus	9.29e-07	1.67e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	9.22e-07	1.66e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	9.15e-07	1.65e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IL6—systemic lupus erythematosus	8.98e-07	1.62e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	7.67e-07	1.38e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	7.67e-07	1.38e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	7.61e-07	1.37e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	6.89e-07	1.24e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	6.59e-07	1.19e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	6.03e-07	1.09e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	5.02e-07	9.04e-06	CbGpPWpGaD
